Literature DB >> 2984568

Screening donated blood and plasma for HTLV-III antibody. Facing more than one crisis?

M T Osterholm, R J Bowman, M W Chopek, J J McCullough, J A Korlath, H F Polesky.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2984568     DOI： 10.1056/NEJM198505023121810

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  AIDS prodrome in an apparently normal man following coronary artery bypass: new significance of postoperative bleeding.

Authors:  A P Weiland; Y Daskal; R Kerman; R W Smalling; J P Williams; W E Walker
Journal:  Tex Heart Inst J       Date:  1985-06

2.  HTLV-III, haemophilia, and blood transfusion.

Authors:  A L Bloom; C D Forbes; C R Rizza
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-22

3.  Acquired immunodeficiency syndrome: ethical and psychosocial considerations.

Authors:  F Rosner
Journal:  Bull N Y Acad Med       Date:  1987-03

Review 4.  AIDS screening, confidentiality, and the duty to warn.

Authors:  L Gostin; W J Curran
Journal:  Am J Public Health       Date:  1987-03       Impact factor: 9.308

5.  Polyvalent immunoglobulins for prophylaxis of bacterial infections in patients following multiple trauma. A randomized, placebo-controlled study.

Authors:  W Glinz; P J Grob; U E Nydegger; T Ricklin; F Stamm; D Stoffel; A Lasance
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

6.  AIDS antibody testing and counseling.

Authors:  G H Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1985-11-16

7.  Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.

Authors:  R S Smith; R B Naso; J Rosen; A Whalley; Y L Hom; K Hoey; C J Kennedy; J A McCutchan; S A Spector; D D Richman
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

8.  AIDS: medicolegal considerations for Canadian hospitals.

Authors:  B J Johnson; C L Soskolne
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262

9.  Demonstration of antibodies to the surface (anti-p41) and core proteins (anti-p24) of the human immunodeficiency virus (HIV) in individuals positive for anti-HIV.

Authors:  G Hess; C Kroegel; G Ramadori; H Rieder; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1987-07-01

10.  Rapid bacterial antigen detection is not clinically useful.

Authors:  M D Perkins; S Mirrett; L B Reller
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.